Dr. Chris Aiken and Kellie Newsome, PMHNP have covered lithium quite a bit on The Carlat Psychiatry Podcast. Are you up to date on this cornerstone of psychiatry? Here's a clearinghouse of lithium episodes to catch you up.
For 23 years, Dr. Carlat and his team of clinical experts have developed a mountain of peer-reviewed articles and books covering almost every aspect of psychiatry. Unlike many journals, these resources are straightforward, plain spoken, and actionable for the everyday work clinicians face. This year we took that massive archive and put it to work for you in a brand new interface called AskCarlat AI.
Five free episodes on the issues that matter most in child and adolescent psychiatry today — from suicide risk in autistic youth to anxiety, sleep, legal systems, and expanding access to care. Hosted by Dr. Joshua Feder and Mara Goverman, LCSW.
One of our most popular 2025 podcast series is now available in full. Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, and Kellie Newsome, PMHNP share expert tips on drug titration — including psych meds that are better tolerated when started faster, and one that must be launched at a high dose and then tapered down to a low maintenance dose. (Spoiler: it’s not buprenorphine.)
Our most-listened-to podcast series is now available in full — all ten episodes, free to stream. Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, and Kellie Newsome, PMHNP distill ten essential principles every prescriber should know about psychopharmacology: the rules that keep patients safe, the pitfalls that catch clinicians off guard, and the evidence that should guide your prescribing every day.
In August 2024, the American Journal of Psychiatry published a landmark update on PTSD by Arieh Shalev, MD, and colleagues at NYU — a comprehensive look at the diagnosis, neuroscience, and treatment of one of psychiatry’s most complex conditions. Dr. Chris Aiken, Editor-in-Chief of The Carlat Psychiatry Report, and his co-host Kellie Newsome, PMHNP took a deep dive into that article in this five-part podcast series.
When Dr. Chris Aiken opened a psychotherapy practice in Western North Carolina, treatment-resistant depression wasn’t a specialty he planned for — it was what walked through the door. Most patients arrived having already failed one or more SSRIs prescribed in primary care. The standard next steps — raising the dose, switching classes, adding bupropion, buspirone, or a stimulant — often weren’t enough.